Trichomoniasis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S [2]

Overview

Routine screening is recommended for asymptomatic HIV-positive individuals and for all individuals identified as being at increased risk of infection.^[1]^[2]

Screening

Routine screening is recommended for the following individuals:^[1]^[2]

HIV-positive (annually)
Multiple sexual partners
Unprotected sexual intercourse
Illict drug use
Previous history of STD
Individuals receiving care in high-prevalence areas

References

↑ ^1.0 ^1.1 http://www.cdc.gov/std/tg2015/trichomoniasis.htm Accessed on September 14, 2016
↑ ^2.0 ^2.1 Coleman JS, Gaydos CA, Witter F (2013). “Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies”. Obstet Gynecol Surv. 68 (1): 43–50. doi:10.1097/OGX.0b013e318279fb7d. PMC 3586271. PMID 23322080.

Template:WH Template:WS

[CDT-1] 1.0 ^1.1 http://www.cdc.gov/std/tg2015/trichomoniasis.htm Accessed on September 14, 2016

[pmid23322080-2] 2.0 ^2.1 Coleman JS, Gaydos CA, Witter F (2013). “Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies”. Obstet Gynecol Surv. 68 (1): 43–50. doi:10.1097/OGX.0b013e318279fb7d. PMC 3586271. PMID 23322080.

[1]

[2]

Trichomoniasis screening

Overview

Screening

References

Looking for the patient version?